يعرض 1 - 10 نتائج من 69 نتيجة بحث عن '"Rodríguez-Antolín, Carlos"', وقت الاستعلام: 0.86s تنقيح النتائج
  1. 1
    دورية أكاديمية

    العلاقة: This work was supported by a grant from the Instituto de Salud Carlos III to LF PI21/01049, the II and V awards from UNOENTRECIENMIL Foundation, and a grant from CRIS FOUNDATION to Beat Cancer as part of the projects “Cell therapybased on NKG2D-CAR for pediatric leukemia” and “NKG2D-CAR as treatment for pediatric patients suffering from acute leukemia and juvenile myelomonocytic leukemia”. AF, MI-N, AN-Z and CF have been supported by Personnel research grants from CRIS Foundation to beat cancer. CM has been supported by Personnel PhD student grants from the Instituto de Salud Carlos III (ISCIII), PFIS (FI19/00176). MVG is funded by grant PID2021-123795OB-I00 from the Spanish Ministry of Science and Innovation [Ministerio de Ciencia e Innovación (MCIN)/Agencia Estatal de Investigación (AEI) / 10.13039/501100011033 and European Regional Development Fund (ERDF)-A way of making Europe] and belongs to cancer-Hub CSIC. MI lab is funded by grant PID2020-114148RB-I00 from the Spanish Ministry of Science and Innovation MCIN/AEI/10.13039/ 501100011033,which was in part granted with FEDER funding (EC).; Iba´ ñez-Navarro M, Ferna´ ndez A, Escudero A, Esteso G, Campos-Silva C, Navarro-Aguadero MA´, Leivas A, Caracuel BR, Rodr´ıguez-Antol´ın C, Ortiz A, Navarro-Zapata A, Mestre-Dura´ n C, Izquierdo M, Balaguer-Pe´ rez M, Ferreras C, Martínez-López J, Vale´ s-Go´ mez M, Pe´rez-Mart´ınez A and Ferna´ ndez L (2023) NKG2D-CAR memory T cells target pediatric T-cell acute lymphoblastic leukemia in vitro and in vivo but fail to eliminate leukemia initiating cells. Front. Immunol. 14:1187665. doi:10.3389/fimmu.2023.1187665; https://hdl.handle.net/20.500.12412/5672Test

  2. 2
    دورية أكاديمية
  3. 3
  4. 4
    دورية أكاديمية
  5. 5
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية

    المساهمون: UAM. Departamento de Obstetricia y Ginecología

    مصطلحات موضوعية: FKBP1B, Methylation, Ovarian cancer, PAX9, Platinum, Predictive, Therapy, Medicina

    وصف الملف: application/pdf

    العلاقة: Clinical Epigenetics; Gobierno de España. PI15/00186; Gobierno de España. PI18/0050; Clinical Epigenetics 13 (2021): 167; 1868-7075 (print); 1868-7083 (online); http://hdl.handle.net/10486/705085Test; 167-1; 167-18; 13

  8. 8
    دورية أكاديمية

    المساهمون: UAM. Departamento de Bioquímica

    مصطلحات موضوعية: Dp_qMSP, Glioblastoma, MGMT methylation, MSP, Medicina

    وصف الملف: application/pdf

    العلاقة: Clinical Epigenetics; Gobierno de España. PI18/00050; Gobierno de España. DTS20/00029; Clinical Epigenetics 13 (2021): 52; 1868-7075 (print); 1868-7083 (online); http://hdl.handle.net/10486/705080Test; 52-1; 52-13; 13

  9. 9
    دورية أكاديمية

    مصطلحات موضوعية: Genetics, Genetik

    وصف الملف: application/pdf

    العلاقة: Genome Biology, 1465-6906, 2021, 22:1; orcid:0000-0001-8699-9959; orcid:0000-0002-4254-7122; orcid:0000-0002-2775-6516; orcid:0000-0001-6682-0771; http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-462226Test; PMID 34872606; ISI:000727334200003

  10. 10
    دورية أكاديمية

    المساهمون: Masira

    مصطلحات موضوعية: PAX9, FKBP1B, Ovarian cancer, Methylation, Predictive, Platinum, Therapy

    وصف الملف: 18 p; application/pdf

    العلاقة: 18; 13; Soto JA, Rodríguez-Antolín C, Vera O, Pernía O, Esteban-Rodríguez I, Dolores Diestro M, Benitez J, Sánchez-Cabo F, Alvarez R, De Castro J, Ibanez de Cáceres I. Transcriptional epigenetic regulation of Fkbp1/Pax9 genes is associated with impaired sensitivity to platinum treatment in ovarian cancer. Clin Epigenetics. 2021 Aug 28;13(1):167. doi:10.1186/s13148-021-01149-8. PMID: 34454589; PMCID: PMC8401184.; Scopus; Clinical Epigenetics; https://repositorio.udes.edu.co/handle/001/6153Test